Download A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurren

Queue processing for download document No title

You can start your download in 30 seconds

Recommend Documents
Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG)

99 67 777KB

A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR -mutated, MET -amplifi

147 86 753KB

A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer p

111 17 944KB

Durvalumab

111 47 167KB

Durvalumab

112 80 166KB

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally ad

156 97 923KB

Atezolizumab/durvalumab

167 74 165KB

Durvalumab

126 6 165KB

Durvalumab

122 113 166KB

Designing Group Sequential Trials with Survival Endpoints

172 43 368KB

Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetax

162 79 2MB

GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials

176 35 2MB